Skip to content

Quantra QStat Sample Type Comparison

Impact of Sample Type on the Performance of the Quantra QStat System

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06025708
Enrollment
25
Registered
2023-09-06
Start date
2023-09-11
Completion date
2024-03-01
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coagulation Defect; Bleeding

Keywords

Quantra, Liver transplantation, Coagulation

Brief summary

This is a single center prospective observational study to compare QStat parameter measurements in arterial and venous blood samples collected in parallel from patients undergoing liver transplantation.

Detailed description

In this single center prospective observational study, 25 cardiac surgery subjects will enrolled, each with parallel artrial and venous samples collected at 3 time points to yield 75 matched samples for analysis on the Quantra System with the QStat Cartridge.

Interventions

DEVICEDiagnostic Test: Quantra QStat Cartridge

Whole blood coagulation testing system

Sponsors

HemoSonics LLC
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subject is \>=18 years * Subject is scheduled for liver transplant surgery * Subject or subject's legally authorized representative (LAR) is willing to provide informed consent

Exclusion criteria

* Subject is younger than 18 years of age * Subject is pregnant * Subject is incarcerated at the time of the study * Subject is affected by a condition that, in the opinion of the treatment team, may pose additional risks * Subject, or subject's LAR, is unable or unwilling to provide informed consent

Design outcomes

Primary

MeasureTime frameDescription
Comparison of QStat Platelet Contribution to Clot stiffness (PCS) in arterial and venous samplesDuring liver transplantation surgeryCoagulation function assessed in two sample types
Comparison of QStat Clot time (CT) in arterial and venous samplesDuring liver transplantation surgeryCoagulation function assessed in two sample types
Comparison of QStat Clot stiffness (CS) in arterial and venous samplesDuring liver transplantation surgeryCoagulation function assessed in two sample types
Comparison of QStat Fibrinogen Contribution to Clot stiffness (FCS) in arterial and venous samplesDuring liver transplantation surgeryCoagulation function assessed in two sample types
Comparison of QStat Clot Stabilty to Lysis (CSL) in arterial and venous samplesDuring liver transplantation surgeryCoagulation function assessed in two sample types

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026